TENAX THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
TENAX THERAPEUTICS, INC. (TENX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$15.29 thousand for the 8-month period ending 2015-12-31, per its 10-KT filed 2016-03-14.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2016-03-14
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2014 was $827.28K, a 48.04% decline from fiscal 2013.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2013 was $1.59M, a 9.14% increase from fiscal 2012.
- TENAX THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2012 was $1.46M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 8 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|---|
| 2015-12-31 | -$15.29K 10-KT · filed 2016-03-14 | |
| 2015-04-30 | $0.00 10-K · filed 2015-07-14 | |
| 2014-04-30 | $827.28K 10-KT · filed 2016-03-14 | |
| 2013-04-30 | $1.59M 10-K · filed 2014-07-29 | |
| 2012-04-30 | $1.46M 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |